Bank of America Downgrades Sarepta Therapeutics To Neutral By: Benzinga via Benzinga May 21, 2015 at 08:38 AM EDT Bank of America downgraded Sarepta Therapeutics Inc (NASDAQ: SRPT) from Buy to Neutral. The price target for Sarepta Therapeutics has ... Read More >> Related Stocks: Sarepta Therapeutics